The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 24,901–25,000 of 31,469
Ando, H., Ushijima, K., Hosohata, K., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04358.x · Cited by 4
An integrative view on the carotid artery alterations in metabolic syndrome
Wang, Z., Gong, H., Shang, Y., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02605.x · Cited by 4
Martínez‐Hervás, S., Priego, A., Lorente, R., et al. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2010.12.009 · Cited by 4
Elevated Glutathione Peroxidase in Newly Diagnosed Hypertension: Its Relation to Insulin Resistance
Selvaraj, N., Sathiyapriya, V., Bobby, Z., Nandeesha, H., & Aparna, A. (2012) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2012.712178 · Cited by 4
Güldiken, S., Demir, M., Arıkan, E., Azcan, Ş., & Tuğrul, A. (2008) · The Endocrinologist · doi:10.1097/ten.0b013e3181652c8d · Cited by 4
Insulin resistance is not associated with thermogenic effect of a high-fat meal in obese children
Chan, J., Lomenick, J. P., Buchowski, M. S., & Shoemaker, A. H. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.06.003 · Cited by 4
IL-4 and IL-6 levels and adipose tissue distribution in HIV-1 patients under antiretroviral therapy
Belo, S., Santos, A. C., Madureira, A. J., Pereira, J., Sarmento, A., Carvalho, D. M., & Freitas, P. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0256-0 · Cited by 4
Fontbonne, A., Cournil, A., Cames, C., et al. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70257-7 · Cited by 4
Bunout, D. C., Barrera, G., de la Maza, M. P., Leiva, L., & Hirsch, S. (2014) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12231 · Cited by 4
Insulin Resistance and Left Ventricular Mass in Non-Diabetic Hemodialysis Patients
Karakan, Ş., Sezer, S., & Özdemir, F. N. (2012) · Current Therapeutic Research · doi:10.1016/j.curtheres.2012.09.001 · Cited by 4
Cardiometabolic risk factors and TV watching in a rural community in West Bengal, India
Nag, T., & Ghosh, A. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.04.013 · Cited by 4
Brachial-ankle pulse wave velocity is a predictor of walking distance in community-dwelling adults
Kawamoto, R., Kohara, K., Katoh, T., Kusunoki, T., Ohtsuka, N., Abe, M., Kumagi, T., & Miki, T. (2014) · Aging Clinical and Experimental Research · doi:10.1007/s40520-014-0262-7 · Cited by 4
Stress hyperglycaemia in hospitalized patients with coronary artery disease and type 2 diabetes risk
Colomo, N., Linares, F., Rubio‐Martín, E., Moreno, M. J., de Mora, M., García, A. M. A., González, A. M., Rojo‐Martínez, G., Valdés, S., de Adana, M. S. R., et al. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12144 · Cited by 4
SIMONE, G. D., Arnett, D. K., Chinali, M., Marco, M. D., Rao, D. C., Kraja, A. T., Hunt, S. C., & Devereux, R. B. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.02.004 · Cited by 4
Maffeis, C., Bonadonna, R. C., Maschio, M., Aiello, G., Tommasi, M., Marigliano, M., Fornari, E., & Morandi, A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.86 · Cited by 4
Cieslak, F., Milano, G. E., Lopes, W. A., Radominski, R. B., Filho, N. A. R., & Leite, N. (2009) · Acta Scientiarum Health Sciences · doi:10.4025/actascihealthsci.v32i1.6476 · Cited by 4
Bartual, A., González, C., Martínez‐Hervás, S., Real, J. T., García-García, A.-B., Cabezas, M. C., Chaves, F. J., Priego, M. A., Ascaso, J. F., & Carmena, R. (2006) · Revista Clínica Española · doi:10.1157/13088559 · Cited by 4
Modulators of erythrocyte glutathione peroxidase activity in healthy adults: An observational study
Barbosa, K. B. F., Volp, A. C. P., Marques-Rocha, J. L., Ribeiro, S. M. R., Navarro-Blasco, Í., Zulet, M. Á., Martínez, J. A., & Bressan, J. (2014) · Redox Report · doi:10.1179/1351000214y.0000000098 · Cited by 4
The effect of antenatal factors and postnatal growth on serum adiponectin levels in children
Boyne, M. S., Thompson, D. S., Osmond, C., et al. (2013) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174413000226 · Cited by 4
Ochoa, J. E., Gallo‐Villegas, J., Correa, M., Zapata, N., McEwen, J. G., Bilo, G., Aristizábal, D., & Parati, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1799 · Cited by 4
Hoetzer, G. L., Irmiger, H. M., Stauffer, B. L., & DeSouza, C. A. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.01.028 · Cited by 4
Diamond, M. P., Chauhan, S., Kruger, M. L., & Subramanian, M. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01016-1 · Cited by 4
Li, M., Feng, Q., Li, L., et al. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12307 · Cited by 4
Lin, Y., Ho, Y., Lee, J., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.12.032 · Cited by 4
Rout, J., Dasgupta, A., Singh, O., Banerjee, U., & Das, B. (2012) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.102605 · Cited by 4
Kawada, T. (2012) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e31825335ae · Cited by 4
Circunferencia de la cintura y riesgo cardiovascular y metabólico
Formiguera, X. (2005) · Medicina Clínica · doi:10.1157/13076476 · Cited by 4
Jaime Pajuelo, R., Hugo Arbañil, H., González, J. S., Gonzáles, D. G., Harold Torres, A., Pando, R., & Agüero-Zamora, R. (2014) · Anales de la Facultad de Medicina · doi:10.15381/anales.v75i2.8386 · Cited by 4
Share, B. L., Naughton, G. A., Obert, P., Peat, J. K., & Kemp, J. G. (2013) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2013.09.011 · Cited by 4
Predictors of Postpartum Lipid Abnormalities in Women with Gestational Diabetes
Edwards, A. M., Meltzer, S., Rahme, E., & Dasgupta, K. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.10.003 · Cited by 4
Insulin Resistance during Puberty in Non-obese Japanese Children
Morimoto, S., & Urakami, T. (2011) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.20.1 · Cited by 4
Kutoh, E., & Yamashita, H. (2012) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-1-17 · Cited by 4
Miyatake, N., Miyachi, M., Tabata, I., et al. (2009) · Anti-aging Medicine · doi:10.3793/jaam.6.41 · Cited by 4
Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis
Shoukry, A., El-Sherbieny, I., & Swelam, E. (2011) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2011.08.005 · Cited by 4
Buyse, S., & Valla, D. C. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)89371-7 · Cited by 4
Effects of Exenatide in a Morbidly Obese Patient with Type 2 Diabetes
Kishimoto, M., & Noda, M. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0050-6 · Cited by 5
Longenberger, A. H., Lim, J. Y., Orchard, T. J., Brooks, M. M., Brach, J. S., Mertz, K. J., & Kingsley, L. (2008) · Future HIV Therapy · doi:10.2217/17469600.2.6.539 · Cited by 4
One hundred and twenty-five years and counting: into an era of systems dermatology
Reynolds, N. J. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13447 · Cited by 4
Nishimura, M., Sakoda, C., Murakawa, M., et al. (2011) · Nephron Clinical Practice · doi:10.1159/000329112 · Cited by 4
The nuclear receptor coactivator AIB3 is a modulator of HOMA β‐cell function in nondiabetic children
Burghardt, H. E., López‐Bermejo, A., Baumgartner, B. G., Ibáñez, L., Vendrell, J. J., Ricart, W., Palacı́n, M., Fernández‐Real, J. M., & Zorzano, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03232.x · Cited by 4
The Association between Type 2 Diabetes Mellitus and Colorectal Cancer
Yi, B. D., Bae, Y. P., Kim, B. G., Park, J. W., Kim, D. H., Park, J. Y., Choi, S., Park, H. S., Lee, J., Lee, C. W., et al. (2011) · Endocrinology and Metabolism · doi:10.3803/enm.2011.26.2.126 · Cited by 4
Biomarkers of Oxidative DNA Damage and Soluble Fas/Fas Ligand in Type 2 Diabetic Patients
Siew (2012) · American Journal of Applied Sciences · doi:10.3844/ajassp.2012.450.458 · Cited by 4
Lü, Y., Lu, Y., Cheng, X., Li, H., & Zhou, Y. (2012) · Asian Biomedicine · doi:10.5372/1905-7415.0605.118 · Cited by 4
Influence of ß2-adrenoceptor gene polymorphisms on diet-induced thermogenesis
Oomen, J., Waijers, P. M., van Rossum, C. T. M., et al. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20051516 · Cited by 4
Ryoo, J., Park, S. K., Hong, H. P., Kim, M., & Ha, C. S. (2015) · Clinical Endocrinology · doi:10.1111/cen.12843 · Cited by 5
Hopper, M. K., Brown, G. W., Funke, K. A., & Brown, L. R. P. (2011) · Journal of American College Health · doi:10.1080/07448481.2011.562577 · Cited by 4
Noushabadi, M. A., & Abedi, B. (2012) · Cited by 4
Impaired renal function and atherosclerosis in a Pakistani cohort
Wierzbicki, A. S., Nishtar, S., Lumb, P. J., et al. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x53270 · Cited by 4
Kubicky, R. A., Dunne, C., Nandi-Munshi, D., & Luca, F. D. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-16 · Cited by 4
Clinical potential of resistin as a novel prognostic biomarker for cellulitis
Ertürk, A., Cüre, M. C., Cüre, E., et al. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2311 · Cited by 4
Park, E., Shin, M., & Chung, N. (2007) · Nutrition Research and Practice · doi:10.4162/nrp.2007.1.1.65 · Cited by 4
Waist circumference and insulin resistance in elderly men: an analysis of Kahrizak elderly study
Mirarefin, M., Sharifi, F., Fakhrzadeh, H., Amini, M., Ghaderpanahi, M., Shoa, N. Z., Badamchizadeh, Z., Tajalizadekhoob, Y., Nazari, N., & Larijani, B. (2014) · Journal of Diabetes and Metabolic Disorders · doi:10.1186/2251-6581-13-28 · Cited by 3
Oliver, P., Caimari, A., Díaz‐Rúa, R., & Palou, A. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100434x · Cited by 4
Koshy, M., Sethupathy, S., & Santha, K. (2013) · Cited by 4
Aggarwal, S., Goel, A., & Jain, A. (2010) · International Journal of Pharma and Bio Sciences · Cited by 4
Ariffin, F. D., Ismail, A. A. A., Tan, V. P. S., Zurkurnai, Y., Awang, S. A., Rani, W. R. W. A., & Rasool, H. G. (2014) · Asian Biomedicine · doi:10.5372/1905-7415.0802.278 · Cited by 4
Zehsaz, F., Farhangi, N., & Mirheidari, L. (2014) · Central European Journal of Immunology · doi:10.5114/ceji.2014.45949 · Cited by 4
Age-Dependent Onset of Insulin Resistance in Insulin-Resistant Mice
Ide, N., Arisawa, K., Ogura, K., Kagawa, Y., & Maeda, T. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00602 · Cited by 4
TG/HDL-C Ratio: A Surrogate Marker of Insulin Resistance in Patients with Metabolic Syndrome
Samant, P., Chavan, P., & Rai, S. (2013) · MGM Journal of Medical Sciences · doi:10.5005/jp-journals-10036-1004 · Cited by 4
Serafi, T. I. E., Awad, M. M., Eldeen, L. A. T., et al. (2013) · Egyptian Liver Journal · doi:10.1097/01.elx.0000427103.05494.6c · Cited by 4
Insulin and Fiber Type in the Offspring of T2DM Subjects with Resistance Training and Detraining
Schofield, K., Rehrer, N. J., Perry, T., Ross, A., Andersen, J. L., & Osborne, H. (2012) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318268008f · Cited by 4
Mauriège, P., Joanisse, D. R., Cartier, A., Lemieux, I., Bergeron, J., Biron, S., Marceau, P., & Richard, D. (2015) · Adipocyte · doi:10.1080/21623945.2015.1103404 · Cited by 4
Ding, L., Hou, X., Ma, X., Zong, W., Lu, H., Xiang, K., & Jia, W. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31821f5eff · Cited by 4
Lin, J., Wu, C., Tang, W.-H., Kuo, F.-C., Pei, D., Liang, Y.-J., & Chen, Y. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.03.007 · Cited by 5
Trace glucose fluxes in individuals with prediabetes using stable isotopes
Du, S., Xia, F., Xu, X., Zhang, H., Zhu, C., & Lu, Y. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20140001 · Cited by 4
Lim, M. H., Oh, T. J., Choi, K., Lee, J. C., Cho, Y. M., & Kim, S. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.4.308 · Cited by 4
Liu, T. (2016) · Clinical Nursing Research · doi:10.1177/1054773816658644 · Cited by 7
Dimova, R. B., Tankova, T. I., Кirilov, G., Chakarova, N. Y., Dakovska, L. N., & Grozeva, G. G. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0165-1 · Cited by 4
Nakamura, A., Iwami, D., Miyoshi, H., Morita, K., Taguri, M., Terauchi, Y., Shinohara, N., & Atsumi, T. (2016) · Diabetic Medicine · doi:10.1111/dme.13199 · Cited by 4
Ryoo, J., Hong, H. P., Park, S. K., Ham, W. T., & Chung, J. Y. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.11.1761 · Cited by 4
Berezin, A. Е. (2015) · Journal of Gerontology & Geriatric Research · doi:10.4172/2167-7182.1000199 · Cited by 4
Zemlin, A. E., Matsha, T. E., Kengne, A. P., Hon, G. M., & Erasmus, R. T. (2016) · Journal of Medical Biochemistry · doi:10.1515/jomb-2016-0024 · Cited by 4
Duong, J. K., de Winter, W., Choy, S., Plock, N., Naik, H., Krauwinkel, W. J. J., Visser, S. A. G., Verhamme, K. M. C., Sturkenboom, M., Stricker, B. H. C., et al. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13144 · Cited by 4
Aydın, H. A., Uysal, A. D., Erol, O. Ö., Elli̇dağ, H. Y., Bayindir, A., & Yılmaz, N. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1236241 · Cited by 4
Drouin‐Chartier, J., Tremblay, A. J., Hogue, J., Leclerc, M., Labonté, M., Marin, J., Lamarche, B., & Couture, P. (2016) · Metabolism · doi:10.1016/j.metabol.2016.11.019 · Cited by 4
Nițescu, M. (2016) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2016.493 · Cited by 4
Groot, C., van der Grond, J., Delgado, Y., et al. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0289 · Cited by 4
Nakahara, T., Aikata, H., Chayama, K., Imajo, K., Nakajima, A., Yoneda, M., Itoh, S. Y., Eguchi, Y., Fujii, H., Ono, M., et al. (2014) · Cited by 4
Takeda, Y., Fujita, Y., Yanagimachi, T., Honjo, J., Abiko, A., Asai, M., & Haneda, M. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0137 · Cited by 4
Gomes, J. M. G., Costa, J. D. A., & Alfenas, R. D. C. G. (2017) · International Dairy Journal · doi:10.1016/j.idairyj.2017.05.001 · Cited by 4
Healthy lifestyle and glucagon-like peptide-1 in young and healthy adults: A population-based study
Krisai, P., Aeschbacher, S., Repilado, F. J. R., Schoen, T., Reusser, A., Meier, M., Todd, J. A., Estis, J., Risch, M., Risch, L., et al. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.05.025 · Cited by 4
Малачкова, Н. В., Komarovska, I. V., & Kyryliuk, M. L. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.13.3.2017.104108 · Cited by 4
Yu, J. H., Baik, I., Cho, H. J., Seo, J. A., Kim, S. G., Choi, K. M., Baik, S. H., Choi, D. S., Shin, C., & Kim, N. H. (2017) · Medicine · doi:10.1097/md.0000000000007565 · Cited by 4
Yiğitbaşı, T., Baskın, Y., Akgöl, E., et al. (2017) · Revista română de medicină de laborator · doi:10.1515/rrlm-2017-0020 · Cited by 4
Guasti, L., Gaudio, G. V., Lupi, A., D'Avino, M., Sala, C., Mugellini, A., Vulpis, V., Felis, S., Sarzani, R., Vanasia, M., et al. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s134826 · Cited by 4
Seo, D. H., Cho, Y., Lee, S. J., Park, S., Kim, S. I., Park, B., & Rhee, Y. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.205 · Cited by 5
Morselli, L. L., Gamazon, E. R., Tasali, E., Cox, N. J., Cauter, E. V., & Davis, L. K. (2017) · Diabetes · doi:10.2337/db16-1229 · Cited by 4
Ratneswaran, C., Sagoo, M. K., & Steier, J. S. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.10.162 · Cited by 6
Predictors of Insulin Resistance in Obesity and Type 2 Diabetes Mellitus - The Role of Magnesium
Milbouw, S., Verhaegen, J., Verrijken, A., et al. (2017) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000235 · Cited by 4
EVALUATION OF α-GLUCOSIDASE INHIBITORY POTENTIAL OF METHANOLIC LEAF EXTRACT OF OCIMUM CANUM
Smita, K. (2018) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2018v10i1.22268 · Cited by 4
Physiologic Interpretation of GWAS Signals for Type 2 Diabetes
Watanabe, R. M. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7471-9_18 · Cited by 5
The Relation Between Vitamin D Level and Hepatosteatosis in Obese Children
Dursun, F. (2018) · Northern Clinics of Istanbul · doi:10.14744/nci.2018.26097 · Cited by 4
Boyer, M., Lévesque, V., Poirier, P., Marette, A., Mitchell, P. L., Mora, S., Mathieu, P., Després, J., Larose, É., & Arsenault, B. J. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008681 · Cited by 4
Namekawa, J., Nemoto, S., SUNADA, G., TAKANASHI, Y., Fujio, S., Shirai, M., & Fumitoshi, A. S. A. I. (2018) · Journal of Veterinary Medical Science · doi:10.1292/jvms.18-0306 · Cited by 4
Seasonal variations of changes in lipid and glucidic variables after bariatric surgery
Cambras, T., Pardina, E., Carmona, J., Ricart-Jané, D., Miñarro, A., Ferrer, R., Lecube, A., Balibrea, J. M., Caubet, E., González, Ó., et al. (2018) · Chronobiology International · doi:10.1080/07420528.2018.1533560 · Cited by 4
El‐Ashmawy, N. E., Al‐Ashmawy, G. M., & Kamel, A. A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.049 · Cited by 4
Aller, R., Primo, D., Izaola, O., & de Luis, D. A. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.11.013 · Cited by 4
Çalan, M., Biçer, M., Alan, M., Alarslan, P., Güler, A., Kocabaş, G. Ü., İmamoğlu, Ç., Akşit, M., Bozkaya, G., Acara, A. Ç., et al. (2018) · Current Opinion in Gynecology and Obstetrics · doi:10.18314/cogo.v1i1.1284 · Cited by 6
Elfayoumy, K. N., Berengy, M. S., & Emran, T. M. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.18237 · Cited by 4
Hanafy, A. S., Abd-Elsalam, S. M., Ahmed, A. F., et al. (2018) · Journal of Ultrasonography · doi:10.15557/jou.2018.0044 · Cited by 4
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
